|
Name |
chaetoglobosin T
|
Molecular Formula | C32H38N2O3 | |
IUPAC Name* |
(1S,3E,6S,7E,9S,11E,13S,16S,17R,18S)-6-hydroxy-18-(1H-indol-3-ylmethyl)-7,9,15,16-tetramethyl-19-azatricyclo[11.7.0.01,17]icosa-3,7,11,14-tetraene-2,20-dione
|
|
SMILES |
C[C@H]\1C/C=C/[C@H]2C=C([C@H]([C@@H]3[C@@]2(C(=O)/C=C/C[C@@H](/C(=C1)/C)O)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C
|
|
InChI |
InChI=1S/C32H38N2O3/c1-19-9-7-10-24-16-20(2)22(4)30-27(17-23-18-33-26-12-6-5-11-25(23)26)34-31(37)32(24,30)29(36)14-8-13-28(35)21(3)15-19/h5-8,10-12,14-16,18-19,22,24,27-28,30,33,35H,9,13,17H2,1-4H3,(H,34,37)/b10-7+,14-8+,21-15+/t19-,22+,24-,27-,28-,30-,32+/m0/s1
|
|
InChIKey |
KJNZESBAHPOZTI-DYGSJVQXSA-N
|
|
Synonyms |
chaetoglobosin T; CHEBI:68738; Cheatoglobosin T; CHEMBL520219; Q27137157; (1S,3E,6S,7E,9S,11E,13S,16S,17R,18S)-6-hydroxy-18-(1H-indol-3-ylmethyl)-7,9,15,16-tetramethyl-19-azatricyclo[11.7.0.01,17]icosa-3,7,11,14-tetraene-2,20-dione; (3S,3aR,4S,6aS,7E,10S,11E,13S,15E,17aS)-13-hydroxy-3-(1H-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3,3a,4,6a,9,10,13,14-octahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione
|
|
CAS | NA | |
PubChem CID | 11466145 | |
ChEMBL ID | CHEMBL520219 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 498.7 | ALogp: | 4.9 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 82.2 | Aromatic Rings: | 5 |
Heavy Atoms: | 37 | QED Weighted: | 0.369 |
Caco-2 Permeability: | -4.936 | MDCK Permeability: | 0.00000816 |
Pgp-inhibitor: | 0.064 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.054 | 20% Bioavailability (F20%): | 0.209 |
30% Bioavailability (F30%): | 0.159 |
Blood-Brain-Barrier Penetration (BBB): | 0.893 | Plasma Protein Binding (PPB): | 97.77% |
Volume Distribution (VD): | 1.581 | Fu: | 3.75% |
CYP1A2-inhibitor: | 0.216 | CYP1A2-substrate: | 0.329 |
CYP2C19-inhibitor: | 0.93 | CYP2C19-substrate: | 0.587 |
CYP2C9-inhibitor: | 0.796 | CYP2C9-substrate: | 0.552 |
CYP2D6-inhibitor: | 0.494 | CYP2D6-substrate: | 0.783 |
CYP3A4-inhibitor: | 0.963 | CYP3A4-substrate: | 0.275 |
Clearance (CL): | 8.541 | Half-life (T1/2): | 0.081 |
hERG Blockers: | 0.038 | Human Hepatotoxicity (H-HT): | 0.284 |
Drug-inuced Liver Injury (DILI): | 0.186 | AMES Toxicity: | 0.22 |
Rat Oral Acute Toxicity: | 0.968 | Maximum Recommended Daily Dose: | 0.993 |
Skin Sensitization: | 0.433 | Carcinogencity: | 0.368 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.986 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002679 | 0.826 | D02DMQ | 0.264 | ||||
ENC003245 | 0.750 | D0W7WC | 0.255 | ||||
ENC005215 | 0.750 | D01TSI | 0.254 | ||||
ENC003856 | 0.691 | D05EJG | 0.248 | ||||
ENC002440 | 0.643 | D09NNH | 0.247 | ||||
ENC002953 | 0.643 | D0V3ZA | 0.247 | ||||
ENC004473 | 0.626 | D0BV3J | 0.245 | ||||
ENC002120 | 0.621 | D0SP3D | 0.241 | ||||
ENC003226 | 0.606 | D00YLW | 0.234 | ||||
ENC002955 | 0.606 | D02XIY | 0.227 |